Evidence map›Paper›PMID 25101117›Full record

ReviewFrontiers in genetics2014

Receptor tyrosine kinases and schistosome reproduction: new targets for chemotherapy.

Marion Morel, Mathieu Vanderstraete, Steffen Hahnel, Christoph G Grevelding, Colette Dissous

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Marion MorelCenter for Infection and Immunity of Lille, INSERM U1019, CNRS-UMR 8204, Institut Pasteur de Lille, University Lille Nord de France Lille Cedex, France.
Mathieu VanderstraeteCenter for Infection and Immunity of Lille, INSERM U1019, CNRS-UMR 8204, Institut Pasteur de Lille, University Lille Nord de France Lille Cedex, France.
Steffen HahnelBiomedical Centre for Research Seltersberg, Institute of Parasitology, Justus-Liebig-University Giessen Giessen, Germany.
Christoph G GreveldingBiomedical Centre for Research Seltersberg, Institute of Parasitology, Justus-Liebig-University Giessen Giessen, Germany.
Colette DissousCenter for Infection and Immunity of Lille, INSERM U1019, CNRS-UMR 8204, Institut Pasteur de Lille, University Lille Nord de France Lille Cedex, France.
University of Giessen · DECentre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosome parasites still represent a serious public health concern and a major economic problem in developing countries. Pathology of schistosomiasis is mainly due to massive egg production by these parasites and to inflammatory responses raised against the eggs which are trapped in host tissues. Tyrosine kinases (TKs) are key molecules that control cell differentiation and proliferation and they already represent important targets in cancer therapy. During recent years, it has been shown that receptor tyrosine kinases (RTK) signaling was active in reproductive organs and that it could regulate sexual maturation of schistosomes and egg production. This opens interesting perspectives for the control of transmission and pathogenesis of schistosomiasis based on new therapies targeting schistosome RTKs. This review relates the numerous data showing the major roles of kinase signaling in schistosome reproduction. It describes the conserved and particular features of schistosome RTKs, their implication in gametogenesis and reproduction processes and summarizes recent works indicating that RTKs and their signaling partners are interesting chemotherapeutical targets in new programs of control.

Indexed as

chemotherapyreceptor tyrosine kinasereproductionschistosomesignaling

Identifiers

PMID25101117
PMCPMC4102852
OpenAlexW2149299215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.